Related Experiment Video
Updated: Dec 10, 2025

A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
Published on: January 22, 2018
Study Protocol - Insight 46 Cardiovascular: A Sub-study of the MRC National Survey of Health and Development
Sarah Ann Mason1, Lamia Al Saikhan1,2, Siana Jones1
1MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Insights
This study investigates how cardiovascular health impacts cognitive decline and dementia risk. Understanding these links, particularly through advanced brain imaging like functional Near Infrared Spectroscopy (fNIRS), may reveal new ways to prevent dementia.
Area of Science:
- Neuroscience
- Cardiovascular Medicine
- Gerontology
Background:
- Dementia, primarily Alzheimer's disease and vascular cognitive impairment, is a growing public health concern.
- Increasing evidence suggests interactions between neurodegenerative and vascular pathologies contribute to cognitive decline.
- Cardiovascular abnormalities may precede the clinical manifestation of cognitive impairment, but underlying mechanisms remain unclear.
Purpose of the Study:
- To investigate the cardiovascular mechanisms underlying dementia and cognitive decline.
- To elucidate pathological changes preceding dementia by analyzing clinical, cognitive, imaging, and lifestyle data.
- To explore the role of cerebrovascular function in cognitive health.
Main Methods:
- Utilized a sub-sample (n=502) from the Medical Research Council National Survey of Health and Development (NSHD) Insight 46 study.
- Conducted comprehensive cardiovascular phenotyping including blood pressure, echocardiography, and electrocardiography (ECG).
- Employed functional Near Infrared Spectroscopy (fNIRS) to assess cerebrovascular function in participants aged 74.
Main Results:
- Presents a detailed description of the fNIRS protocol for assessing cerebrovascular function.
- Includes preliminary results from pilot data on cerebrovascular function.
- Highlights the integration of cardiovascular data with lifestyle, brain structure/function, and cognitive performance.
Conclusions:
- The combined dataset offers a unique opportunity to understand cardiovascular mechanisms in dementia.
- Identifies potential novel targets for intervention in cognitive decline and dementia prevention.
- Emphasizes the interconnectedness of cardiovascular health and brain function in aging.
Abstract:
The commonest causes of dementia are Alzheimer's disease and vascular cognitive impairment. Although these conditions have been viewed as distinct entities, there is increasing evidence that neurodegenerative and vascular pathologies interact or overlap to cause cognitive decline, and that at least in some cases individuals at risk of cognitive decline exhibit abnormal cardiovascular physiology long before emergence of disease. However, the mechanisms linking haemodynamic disturbances with cognitive impairment and the various pathologies that cause dementia are poorly understood. A sub-sample of 502 participants from the Medical Research Council National Survey of Health and Development (NSHD) have participated in the first visit of a neuroscience sub-study referred to as Insight 46, where clinical, cognitive, imaging, and lifestyle data have been collected for the purpose of elucidating the pathological changes preceding dementia. This paper outlines the cardiovascular phenotyping performed in the follow-up visit of Insight 46, with the study participants now aged 74. In addition to standard cardiovascular assessments such as blood pressure measurements, echocardiography, and electrocardiography (ECG), functional Near Infrared Spectroscopy (fNIRS) has been included to provide an assessment of cerebrovascular function. A detailed description of the fNIRS protocol along with preliminary results from pilot data is presented. The combination of lifestyle data, brain structure/function, cognitive performance, and cardiovascular health obtained not only from Insight 46, but also from the whole NSHD provides an exciting opportunity to advance our understanding of the cardiovascular mechanisms underlying dementia and cognitive decline, and identify novel targets for intervention.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Longitudinal Studies
Imaging Studies for Cardiovascular System IV: CMRI
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

